ASH 2019 Forty Seven’s data eat up the market, with positive results in MDS and AML Dec. 9, 2019 By Lee Landenberger ORLANDO, Fla. – Data from two studies from Forty Seven Inc. announced at the American Society of Hematology (ASH) annual meeting moved the market in a major way Monday as the company stock (NASDAQ:FTSV) soared 111% to close at $30.43, up $15.99.Read More
